Arrhythmias & electrophysiologyCohort study

Left atrial myopathy development and progression in atrial fibrillation patients with recurrent left atrial ablation procedures: The LAMP-AF study

Heart RhythmPublished

  • Consecutive adults undergoing de novo left atrial (LA) ablation for atrial fibrillation (AF) were enrolled, with repeat ablation cases analyzed
  • longitudinal

Authors' conclusion

LA myopathy advances in one-third of repeat AF ablation patients without chamber enlargement, exhibiting heterogeneous progression favoring septal, anterior, and posterior segments while sparing the lateral wall. Baseline CV and LA volume robustly predict LVA progression, indicating functional electrical remodeling precedes structural fibrosis, highlighting the importance of integrating functional markers when characterizing atrial substrate progression.

Study context

Population
Adults undergoing de novo left atrial ablation for AF who had repeat ablation
Participants
90 repeat ablation patients
Exposure
progression vs no progression

Main finding

As reported in the abstract

Total LVA · baseline to repeat procedure

total LVA increased from

9.5 ± 16.8% to 19.0 ± 24.7%

P

P < .001

Observational data: associations, not effects.

Further findings

Outcomeprogressionno progressionEstimateP value
Baseline characteristics by progression
CHA2DS2-VASc2.752.05
LA volume152 mL122 mL
baseline CV0.86 m/s1.02 m/s
12-month AF recurrence predicted by LVA burden — LVA burden (baseline) · baselineodds ratio 3.65 per 1%P = 0.049
12-month AF recurrence predicted by LVA burden — LVA burden (second procedure) · at second procedureodds ratio 2.54P = 0.012
  • Baseline characteristics by progression: CHA2DS2-VASc P = .021
  • Baseline characteristics by progression: LA volume P = .008
  • Baseline characteristics by progression: Conduction velocity (CV) P = .013

Patients with >10% LVA progression

patients with >10% progression
33%
septal
42%
anterior
37%
posterior
34%

Multivariable predictors of progression

baseline LA volume
P = 0.002
CV
P = 0.043
R2
0.206

Original publication

Left atrial myopathy development and progression in atrial fibrillation patients with recurrent left atrial ablation procedures: The LAMP-AF study. Heart Rhythm. Published 5 May 2026. doi:10.1016/j.hrthm.2026.04.056

Summarised from the published abstract; every number is checked against it